社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Shlee
IP属地：未知
+关注
帖子 · 66
帖子 · 66
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Shlee
Shlee
·
2021-12-27
Nice
EV stocks mixed in morning trading<blockquote>早盘交易中电动汽车股涨跌互现</blockquote>
EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and
EV stocks mixed in morning trading<blockquote>早盘交易中电动汽车股涨跌互现</blockquote>
看
3,670
回复
评论
点赞
5
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-23
Nice
Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar：由于 12 月交付强劲，特斯拉第四季度销量预计将增长 43%</blockquote>
Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles
Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar：由于 12 月交付强劲，特斯拉第四季度销量预计将增长 43%</blockquote>
看
4,470
回复
评论
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-17
Nice
非常抱歉，此主贴已删除
看
4,112
回复
1
点赞
2
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-16
Nice
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后，美国股市周四开盘走高，纳斯达克综合指数上涨 0.4%</blockquote>
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%
U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后，美国股市周四开盘走高，纳斯达克综合指数上涨 0.4%</blockquote>
看
4,736
回复
评论
点赞
8
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-14
Nice
非常抱歉，此主贴已删除
看
5,022
回复
1
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-12-10
Beyond meat
3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12 月份值得买入的 3 只高增长股票</blockquote>
Now is a good time to be greedy and buy up these depressed stocks.
3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12 月份值得买入的 3 只高增长股票</blockquote>
看
3,153
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-23
Nice
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作，将其算法用于mRNA疫苗和疗法开发</blockquote>
BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作，将其算法用于mRNA疫苗和疗法开发</blockquote>
看
4,194
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-19
Nice
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>
看
3,102
回复
评论
点赞
3
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-11-16
[OMG]
非常抱歉，此主贴已删除
看
5,786
回复
评论
点赞
1
编组 21备份 2
分享
举报
Shlee
Shlee
·
2021-10-29
Yes!
非常抱歉，此主贴已删除
看
5,029
回复
1
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3573647345754035","uuid":"3573647345754035","gmtCreate":1610556776007,"gmtModify":1706620610298,"name":"Shlee","pinyin":"shlee","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":17,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.93%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696318694,"gmtCreate":1640617094472,"gmtModify":1640617232336,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696318694","repostId":"1139095230","repostType":4,"repost":{"id":"1139095230","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640615948,"share":"https://www.laohunote.com/m/news/1139095230?lang=zh_CN&edition=full","pubTime":"2021-12-27 22:39","market":"us","language":"en","title":"EV stocks mixed in morning trading<blockquote>早盘交易中电动汽车股涨跌互现</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1139095230","media":"Tiger Newspress","summary":"EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and ","content":"<p>EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.</p><p><blockquote>电动汽车股早盘涨跌互现.特斯拉、尼古拉、蔚来、小鹏汽车和理想汽车上涨1%至3%.而Lucid则下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0c26aaadf8023ee7e2e15e128470dc48\" tg-width=\"417\" tg-height=\"660\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks mixed in morning trading<blockquote>早盘交易中电动汽车股涨跌互现</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks mixed in morning trading<blockquote>早盘交易中电动汽车股涨跌互现</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-27 22:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.</p><p><blockquote>电动汽车股早盘涨跌互现.特斯拉、尼古拉、蔚来、小鹏汽车和理想汽车上涨1%至3%.而Lucid则下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0c26aaadf8023ee7e2e15e128470dc48\" tg-width=\"417\" tg-height=\"660\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉","NIO":"蔚来","FSR":"菲斯克","LCID":"Lucid Group Inc","XPEV":"小鹏集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139095230","content_text":"EV stocks mixed in morning trading.Tesla,Nikola,NIO,Xpeng Motors and Li Auto climbed between 1% and 3%.While Lucid fell more than 4%.","news_type":1,"symbols_score_info":{"LI":0.9,"RIVN":0.9,"LCID":0.9,"XPEV":0.9,"NKLA":0.9,"FSR":0.9,"GOEV":0.9,"TSLA":0.9,"ARVL":0.9,"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":3670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698075573,"gmtCreate":1640270565309,"gmtModify":1640270565416,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698075573","repostId":"1140408431","repostType":4,"repost":{"id":"1140408431","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640258815,"share":"https://www.laohunote.com/m/news/1140408431?lang=zh_CN&edition=full","pubTime":"2021-12-23 19:26","market":"us","language":"en","title":"Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar：由于 12 月交付强劲，特斯拉第四季度销量预计将增长 43%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140408431","media":"Benzinga Earnings","summary":"Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles ","content":"<p><b>Tesla Inc’s</b> fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from <b>TrueCar</b> reflected on Wednesday.</p><p><blockquote><b>特斯拉公司</b>根据汽车行业的最新预测，美国第四季度电动汽车销量预计将同比增长 42.8%，达到 97,417 辆，比上一季度增长 28.8%<b>交换车</b>周三反思。</blockquote></p><p> <b>What Happened:</b>The <b>Elon Musk</b>-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.</p><p><blockquote><b>发生了什么：</b>这个<b>埃隆·马斯克</b>-led 公司预计 12 月份将在美国交付 36,300 辆电动汽车，比去年增长 34.7%，比 11 月份增长约 7%。</blockquote></p><p> Tesla sold 33,980 electric vehicles in November, the report noted.</p><p><blockquote>报告指出，特斯拉 11 月份售出 33,980 辆电动汽车。</blockquote></p><p> Musk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.</p><p><blockquote>马斯克周三表示，随着这家电动汽车制造商的股票重新加入 1 万亿美元市值俱乐部，特斯拉正在努力实现年终交付目标。</blockquote></p><p> TrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.</p><p><blockquote>TrueCar 还预测 12 月份新车总销量将达到 1,144,108 辆，同比下降 27%。该研究机构估计，12 月份轻型车总销量的季节性调整年化率（SAAR）为 1190 万辆，比去年同期下降了 27%。</blockquote></p><p> <b>How Will Legacy Players Fare?:</b>Both <b>General Motors Co</b> and <b>Ford Motor Co</b> are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.</p><p><blockquote><b>传统玩家的表现如何？：</b>两者<b>通用汽车公司</b>和<b>福特汽车</b>预计 12 月份销量将同比下降，原因是一年前的基数较低，当时销量因疫情而受到打击，经销商也在库存问题上苦苦挣扎。</blockquote></p><p> The sales numbers are expected to rise over November for both GM and Ford.</p><p><blockquote>通用汽车和福特的销量预计将在 11 月份上升。</blockquote></p><p> GM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.</p><p><blockquote>通用汽车12月销量预计将达到168,640辆，同比下降42.9%，比11月份增长21%。</blockquote></p><p> Ford is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.</p><p><blockquote>福特预计 12 月份销量将比去年同期下降 20%，至 166,547 辆，环比增长 5.8%。</blockquote></p><p> On a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.</p><p><blockquote>按季度来看，福特预计共售出498,428辆汽车，同比下降7.5%，但比第三季度增长25.3%。</blockquote></p><p> GM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.</p><p><blockquote>报告指出，通用汽车预计第四季度总销量为441,426辆，同比下降42.5%，环比下降0.4%。</blockquote></p><p> Historically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.</p><p><blockquote>从历史上看，12 月对于汽车制造商来说是一个繁忙的月份，因为他们急于完成日历年终目标。今年，世界各地的汽车制造商一直在与芯片短缺作斗争，以确保向经销商和客户稳定、及时地供应芯片。传统汽车制造商福特早些时候表示，计划将库存保持在历史低位。</blockquote></p><p> The report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.</p><p><blockquote>该报告预计 12 月份的激励支出将比去年下降 55%，第四季度将下降 51%。</blockquote></p><p> <b>Price Action:</b> Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.</p><p><blockquote><b>价格行为：</b>特斯拉股价周三收盘上涨 7.49%，至每股 1,008.87 美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar：由于 12 月交付强劲，特斯拉第四季度销量预计将增长 43%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q4 Sales Expected To Jump 43% On Robust December Deliveries: TrueCar<blockquote>TrueCar：由于 12 月交付强劲，特斯拉第四季度销量预计将增长 43%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-12-23 19:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Tesla Inc’s</b> fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from <b>TrueCar</b> reflected on Wednesday.</p><p><blockquote><b>特斯拉公司</b>根据汽车行业的最新预测，美国第四季度电动汽车销量预计将同比增长 42.8%，达到 97,417 辆，比上一季度增长 28.8%<b>交换车</b>周三反思。</blockquote></p><p> <b>What Happened:</b>The <b>Elon Musk</b>-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.</p><p><blockquote><b>发生了什么：</b>这个<b>埃隆·马斯克</b>-led 公司预计 12 月份将在美国交付 36,300 辆电动汽车，比去年增长 34.7%，比 11 月份增长约 7%。</blockquote></p><p> Tesla sold 33,980 electric vehicles in November, the report noted.</p><p><blockquote>报告指出，特斯拉 11 月份售出 33,980 辆电动汽车。</blockquote></p><p> Musk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.</p><p><blockquote>马斯克周三表示，随着这家电动汽车制造商的股票重新加入 1 万亿美元市值俱乐部，特斯拉正在努力实现年终交付目标。</blockquote></p><p> TrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.</p><p><blockquote>TrueCar 还预测 12 月份新车总销量将达到 1,144,108 辆，同比下降 27%。该研究机构估计，12 月份轻型车总销量的季节性调整年化率（SAAR）为 1190 万辆，比去年同期下降了 27%。</blockquote></p><p> <b>How Will Legacy Players Fare?:</b>Both <b>General Motors Co</b> and <b>Ford Motor Co</b> are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.</p><p><blockquote><b>传统玩家的表现如何？：</b>两者<b>通用汽车公司</b>和<b>福特汽车</b>预计 12 月份销量将同比下降，原因是一年前的基数较低，当时销量因疫情而受到打击，经销商也在库存问题上苦苦挣扎。</blockquote></p><p> The sales numbers are expected to rise over November for both GM and Ford.</p><p><blockquote>通用汽车和福特的销量预计将在 11 月份上升。</blockquote></p><p> GM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.</p><p><blockquote>通用汽车12月销量预计将达到168,640辆，同比下降42.9%，比11月份增长21%。</blockquote></p><p> Ford is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.</p><p><blockquote>福特预计 12 月份销量将比去年同期下降 20%，至 166,547 辆，环比增长 5.8%。</blockquote></p><p> On a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.</p><p><blockquote>按季度来看，福特预计共售出498,428辆汽车，同比下降7.5%，但比第三季度增长25.3%。</blockquote></p><p> GM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.</p><p><blockquote>报告指出，通用汽车预计第四季度总销量为441,426辆，同比下降42.5%，环比下降0.4%。</blockquote></p><p> Historically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.</p><p><blockquote>从历史上看，12 月对于汽车制造商来说是一个繁忙的月份，因为他们急于完成日历年终目标。今年，世界各地的汽车制造商一直在与芯片短缺作斗争，以确保向经销商和客户稳定、及时地供应芯片。传统汽车制造商福特早些时候表示，计划将库存保持在历史低位。</blockquote></p><p> The report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.</p><p><blockquote>该报告预计 12 月份的激励支出将比去年下降 55%，第四季度将下降 51%。</blockquote></p><p> <b>Price Action:</b> Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.</p><p><blockquote><b>价格行为：</b>特斯拉股价周三收盘上涨 7.49%，至每股 1,008.87 美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140408431","content_text":"Tesla Inc’s fourth-quarter sales in the U.S. are expected to jump 42.8% to 97,417 electric vehicles from a year ago and 28.8% over the previous quarter, the latest automotive industry forecast from TrueCar reflected on Wednesday.\nWhat Happened:The Elon Musk-led company is expected to deliver 36,300 electric vehicles in the U.S. in December, a jump of 34.7% over last year and about 7% over November, according to TrueCar.\nTesla sold 33,980 electric vehicles in November, the report noted.\nMusk on Wednesday said Tesla is working hard to meet the year-end delivery targets as the electric vehicle maker company’s stock rejoined the $1-trillion-market-cap club.\nTrueCar also forecast total new vehicle sales will reach 1,144,108 units in December, down 27% from a year ago. The research agency estimated December’s seasonally adjusted annualized rate (SAAR) for total light-vehicle sales to be 11.9 million units, down 27% from a year ago.\nHow Will Legacy Players Fare?:Both General Motors Co and Ford Motor Co are expected to report year-on-year declines in December sales due to the low base from a year ago when volumes were hit due to the pandemic and dealers were struggling with inventories.\nThe sales numbers are expected to rise over November for both GM and Ford.\nGM’s December sales are expected to reach 168,640 vehicles, a decline of 42.9% on a year-on-year basis, and a rise of 21% over November.\nFord is expected to report a decline of 20% to 166,547 vehicles in December, compared to a year ago, and a rise of 5.8% over last month.\nOn a quarterly basis, Ford is expected to sell a total of 498,428 vehicles, a drop of 7.5% on a year-on-year basis but a rise of 25.3% over the third quarter.\nGM is expected to report total sales of 441,426 vehicles in the fourth quarter, implying declines of 42.5% year-on-year and down 0.4% quarter-on-quarter, the report noted.\nHistorically, December has been a busy month for automakers as they rush to close the calendar year-end targets. This year, automakers around the world have been battling chip shortages to ensure a steady and timely supply to dealerships and customers. Legacy player Ford has earlier said it plans to keep inventories historically low.\nThe report projected incentive spending in December to be down 55% from last year and 51% for the fourth quarter.\nPrice Action: Tesla shares closed 7.49% higher at $1,008.87 a share on Wednesday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4470,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699118924,"gmtCreate":1639755143620,"gmtModify":1639755143863,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699118924","repostId":"2192462941","repostType":2,"isVote":1,"tweetType":1,"viewCount":4112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690648910,"gmtCreate":1639666223435,"gmtModify":1639666223552,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690648910","repostId":"1103611253","repostType":4,"repost":{"id":"1103611253","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639665157,"share":"https://www.laohunote.com/m/news/1103611253?lang=zh_CN&edition=full","pubTime":"2021-12-16 22:32","market":"us","language":"en","title":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后，美国股市周四开盘走高，纳斯达克综合指数上涨 0.4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1103611253","media":"Tiger Newspress","summary":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%","content":"<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.</p><p><blockquote>继周三美联储日反弹后，美国股市周四开盘走高，纳斯达克综合指数上涨0.4%，道琼斯指数上涨0.5%；标普500股市上涨 0.4%，标准普尔 500 指数周四早些时候创下收盘纪录。</blockquote></p><p> Shares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.</p><p><blockquote>在之前的加息周期中表现良好的公司股票领涨盘前涨幅。材料股 FMC Corp. 和 Freeport-McMoRan 在开盘前均上涨超过 3%。银行股也全线上涨，摩根大通、花旗集团和美国银行均上涨约0.6%。</blockquote></p><p> In transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p><p><blockquote>在《交通新闻》中，达美航空公司报告称，在此前预计亏损后，该公司目前预计第四季度利润将达到 2 亿美元。消息传出后，股价上涨 2.2%。</blockquote></p><p> In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p><p><blockquote>在其他央行新闻中，英国央行宣布将关键政策利率上调 15 个基点至 0.25%。市场正在等待欧洲央行的单独政策决定。还有更多经济新闻，每周申请失业救济人数和房屋开工时间为美国东部时间上午 8:30。</blockquote></p><p> Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p><p><blockquote>美联储消息公布后，交易员加快了自己对加息的预期。根据芝加哥商品交易所 FedWatch 的数据，目前交易的联邦基金期货交易显示，2022 年 5 月首次加息的可能性为 63%，央行最早在 3 月份采取首次行动的可能性也上升至约 44%。</blockquote></p><p> Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p><p><blockquote>在周三的常规交易中，股市在整个常规交易时段都处于负值区域，并在美联储主席杰罗姆-鲍威尔（Jerome Powell）下午在为期两天的联邦公开市场委员会会议结束时举行新闻发布会之前走高。道琼斯指数上涨383点，涨幅1.08%。标普500上涨 1.63%，以科技股为主的纳斯达克综合指数上涨 2.15%。</blockquote></p><p> “The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p><p><blockquote>“The Sevens Report 的汤姆-埃萨耶（Tom Essaye）在周四的一份报告中说：”联邦公开市场委员会（FOMC）承认新的 COVID 变种对经济复苏构成威胁，可能会改变未来的政策，再加上鲍威尔在媒体上普遍持乐观态度，这有助于引发美联储会议的缓解反弹。</blockquote></p><p> The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.</p><p><blockquote>美联储将从1月份开始放缓资产购买步伐，今后每月仅购买600亿美元债券，而12月份为900亿美元。这一决定是在最近的通胀数据显示 11 月份飙升 6.8%，高于预期，也是 1982 年以来的最快增速之后做出的。</blockquote></p><p> “The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p><p><blockquote>“安联投资管理公司（Allianz Investment Management）高级投资策略师查理-里普利（Charlie Ripley）说：”通胀水平上升将是暂时的观点终于被美联储抛弃了，最新的政策调整反映出一个委员会不想错过下一班离开车站的火车。</blockquote></p><p> Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p><p><blockquote>周四，企业盈利似乎是市场的薄弱环节，Adobe 和 Lennar 的股价在季度报告令人失望后在盘前交易中下跌。</blockquote></p><p> On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p><p><blockquote>经济数据方面，每周初请失业救济人数略高于预期，而 11 月份新屋开工率在上个月下降后远远强于经济学家的预期。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后，美国股市周四开盘走高，纳斯达克综合指数上涨 0.4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%<blockquote>继周三美联储日上涨后，美国股市周四开盘走高，纳斯达克综合指数上涨 0.4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 22:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.</p><p><blockquote>继周三美联储日反弹后，美国股市周四开盘走高，纳斯达克综合指数上涨0.4%，道琼斯指数上涨0.5%；标普500股市上涨 0.4%，标准普尔 500 指数周四早些时候创下收盘纪录。</blockquote></p><p> Shares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.</p><p><blockquote>在之前的加息周期中表现良好的公司股票领涨盘前涨幅。材料股 FMC Corp. 和 Freeport-McMoRan 在开盘前均上涨超过 3%。银行股也全线上涨，摩根大通、花旗集团和美国银行均上涨约0.6%。</blockquote></p><p> In transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p><p><blockquote>在《交通新闻》中，达美航空公司报告称，在此前预计亏损后，该公司目前预计第四季度利润将达到 2 亿美元。消息传出后，股价上涨 2.2%。</blockquote></p><p> In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p><p><blockquote>在其他央行新闻中，英国央行宣布将关键政策利率上调 15 个基点至 0.25%。市场正在等待欧洲央行的单独政策决定。还有更多经济新闻，每周申请失业救济人数和房屋开工时间为美国东部时间上午 8:30。</blockquote></p><p> Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p><p><blockquote>美联储消息公布后，交易员加快了自己对加息的预期。根据芝加哥商品交易所 FedWatch 的数据，目前交易的联邦基金期货交易显示，2022 年 5 月首次加息的可能性为 63%，央行最早在 3 月份采取首次行动的可能性也上升至约 44%。</blockquote></p><p> Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p><p><blockquote>在周三的常规交易中，股市在整个常规交易时段都处于负值区域，并在美联储主席杰罗姆-鲍威尔（Jerome Powell）下午在为期两天的联邦公开市场委员会会议结束时举行新闻发布会之前走高。道琼斯指数上涨383点，涨幅1.08%。标普500上涨 1.63%，以科技股为主的纳斯达克综合指数上涨 2.15%。</blockquote></p><p> “The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p><p><blockquote>“The Sevens Report 的汤姆-埃萨耶（Tom Essaye）在周四的一份报告中说：”联邦公开市场委员会（FOMC）承认新的 COVID 变种对经济复苏构成威胁，可能会改变未来的政策，再加上鲍威尔在媒体上普遍持乐观态度，这有助于引发美联储会议的缓解反弹。</blockquote></p><p> The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.</p><p><blockquote>美联储将从1月份开始放缓资产购买步伐，今后每月仅购买600亿美元债券，而12月份为900亿美元。这一决定是在最近的通胀数据显示 11 月份飙升 6.8%，高于预期，也是 1982 年以来的最快增速之后做出的。</blockquote></p><p> “The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p><p><blockquote>“安联投资管理公司（Allianz Investment Management）高级投资策略师查理-里普利（Charlie Ripley）说：”通胀水平上升将是暂时的观点终于被美联储抛弃了，最新的政策调整反映出一个委员会不想错过下一班离开车站的火车。</blockquote></p><p> Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p><p><blockquote>周四，企业盈利似乎是市场的薄弱环节，Adobe 和 Lennar 的股价在季度报告令人失望后在盘前交易中下跌。</blockquote></p><p> On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p><p><blockquote>经济数据方面，每周初请失业救济人数略高于预期，而 11 月份新屋开工率在上个月下降后远远强于经济学家的预期。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103611253","content_text":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.\nShares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.\nIn transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.\nIn other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.\nFollowing the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.\nStocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.\n“The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.\nThe Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.\n“The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.\nCorporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.\nOn the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":4736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607353417,"gmtCreate":1639492755940,"gmtModify":1639492763552,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607353417","repostId":"2191932169","repostType":2,"isVote":1,"tweetType":1,"viewCount":5022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605616949,"gmtCreate":1639151363801,"gmtModify":1639151363866,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Beyond meat","listText":"Beyond meat","text":"Beyond meat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605616949","repostId":"1147480652","repostType":2,"repost":{"id":"1147480652","kind":"news","pubTimestamp":1639125342,"share":"https://www.laohunote.com/m/news/1147480652?lang=zh_CN&edition=full","pubTime":"2021-12-10 16:35","market":"us","language":"en","title":"3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12 月份值得买入的 3 只高增长股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147480652","media":"Motley Fool","summary":"Now is a good time to be greedy and buy up these depressed stocks.","content":"<p>If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.</p><p><blockquote>如果你想在圣诞节购买股票，现在有一些非常好的交易。市场并没有崩盘，但一些股票最近一直在挣扎，如果您是长期投资者，您可能不会后悔今天将其添加到您的投资组合中。</blockquote></p><p> Shares of <b>Jazz Pharmaceuticals</b>,<b>DocuSign</b>,and <b>Beyond Meat</b> haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.</p><p><blockquote>股份<b>爵士制药</b>,<b>文档签名</b>,和<b>Beyond Meat</b>已经几个月没这么便宜了。所有这些业务都有可能在未来几个月和几年内产生一些强劲的增长数据，这可能意味着您将获得丰厚的回报。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aaa8c5069132f2d41beafbfbef0705f\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社</span></p></blockquote></p><p> <b>1. Jazz Pharmaceuticals</b></p><p><blockquote><b>1. 爵士制药</b></blockquote></p><p> Healthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the <b>S&P 500</b> is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.</p><p><blockquote>医疗保健公司 Jazz Pharmaceuticals 的股价徘徊在 52 周低点附近，今年迄今已下跌 25%，尽管<b>标普500</b>上涨22%。今年 2 月，该公司宣布收购 GW Pharmaceuticals，该公司生产 Epidiolex，一种治疗癫痫发作的大麻药物。大麻市场的疲软（由于令人失望的合法化步伐）可能在一定程度上影响了股价。</blockquote></p><p> Yet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.</p><p><blockquote>然而，该公司仍有希望。爵士乐在11月份公布了最新的季度业绩，收入同比增长39%，达到8.38亿美元。其中一半以上来自新产品或刚刚收购的产品，例如 Epidiolex。尽管投资者担忧，其销售额仍强劲增长 21%。</blockquote></p><p> In fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.</p><p><blockquote>事实上，Epidiolex 使 Jazz 成为这里一个有前途的买家，因为该公司正在寻找新的适应症；此外，它正在向欧洲的新国家推出Epidiolex。从长远来看，这两项举措都可能提振该药物的销售。</blockquote></p><p> Prospects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.</p><p><blockquote>长期盈利前景看起来也很强劲。该公司在过去四个季度中的每个季度都取得了令人印象深刻的 82% 或更高的毛利率。尽管在收购 GW Pharma 后，其利润已陷入亏损，但这并不是投资者应该期望该公司停留的地方。爵士队现在可能是一笔划算的交易。</blockquote></p><p> <b>2. DocuSign</b></p><p><blockquote><b>2. 文档签名</b></blockquote></p><p> Anytime a stock falls more than 40% in a <i>single day</i>, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.</p><p><blockquote>任何时候股票下跌超过 40%<i>单日</i>，值得追问的是市场是否反应过度。DocuSign似乎就是这样。该公司上周公布第三季度业绩时超出了预期。截至 10 月 31 日的销售额同比飙升 42%，达到 5.455 亿美元。该公司还经常吹嘘毛利润接近80%。</blockquote></p><p> Yet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.</p><p><blockquote>然而，这对投资者来说还不够。这家科技公司提供的第四季度收入指引为 5.57 亿至 5.63 亿美元，随后出现抛售，远低于分析师预期的 5.74 亿美元。虽然这一估计低于分析师的数字，但这似乎很难成为价格出现如此令人难以置信的下跌的理由。</blockquote></p><p> Unfortunately, in the era of meme stocks, where companies with questionable growth prospects such as <b>AMC Entertainment</b> can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.</p><p><blockquote>不幸的是，在模因股票时代，增长前景可疑的公司，例如<b>AMC院线</b>可能会飙升超过 1,000%（主要是由于散户投资者的炒作），像 DocuSign 这样的高质量企业也可能在没有充分理由的情况下大幅下跌。由于一个季度的指导而出现如此大幅的抛售，是短期思维的缩影。</blockquote></p><p> DocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.</p><p><blockquote>随着人们重返办公室，不再如此依赖数字签名，DocuSign的需求可能会有所下降。然而，这并不意味着它的增长已经结束。Fortune Business Insights 的分析师预计，到 2027 年，全球数字签名市场的复合年增长率将达到 28.9%。</blockquote></p><p> So despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.</p><p><blockquote>因此，尽管看跌，DocuSign 的天空并没有塌下来，看起来现在可能是一个便宜货。尽管该股已从上周触及的低点反弹，但仍处于 2020 年 6 月以来的最高水平。</blockquote></p><p> <b>3. Beyond Meat</b></p><p><blockquote><b>3. Beyond Meat</b></blockquote></p><p> Another stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.</p><p><blockquote>另一只在发布财报后陷入困境的股票是Beyond Meat。该股股价略高于 70 美元，接近 52 周低点，今年已下跌 43%。考虑到该公司不幸出现了未达盈利预期的趋势，这并不奇怪。然而，随着经济恢复正常，新冠肺炎不再影响对其产品的需求或扰乱供应链，Beyond Meat是一只值得持有的复苏股票。</blockquote></p><p> In 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).</p><p><blockquote>2019年，该公司2.98亿美元的销售额是2018年8800万美元的三倍多。2020 年，销售额进一步上升至 4.07 亿美元，但增长率要低得多，为 37%。截至 10 月 2 日的最新季度，净收入仅增长 13%，达到 1.06 亿美元，而在美国市场，销售额实际上下降了 14%。正是该公司的国际业务使整体数字保持绿色（增长了令人印象深刻的 143%）。</blockquote></p><p></p><p> However, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant <b>McDonald's</b> with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker <b>PepsiCo</b> to develop new products. Beyond Meat also recently launched meatless chicken tenders.</p><p><blockquote>然而，随着恢复正常，公司业绩应该会有所改善。此外，Beyond Meat还有新产品和交易，可以将其推向比以前更高的高度。它正在向快餐巨头供货<b>麦当劳</b>McPlant 汉堡的馅饼，如果事实证明它是成功的，这可能会给业务带来好处。此外，它还与一家软饮料制造商成立了一家合资企业<b>百事可乐</b>开发新产品。Beyond Meat最近也推出了无肉鸡肉。</blockquote></p><p> Things may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.</p><p><blockquote>Beyond Meat的短期内情况可能会很严峻，但有许多催化剂可能会使其股价在一两年内看起来非常便宜。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12 月份值得买入的 3 只高增长股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Growth Stocks That Are Screaming Buys in December<blockquote>12 月份值得买入的 3 只高增长股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-10 16:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.</p><p><blockquote>如果你想在圣诞节购买股票，现在有一些非常好的交易。市场并没有崩盘，但一些股票最近一直在挣扎，如果您是长期投资者，您可能不会后悔今天将其添加到您的投资组合中。</blockquote></p><p> Shares of <b>Jazz Pharmaceuticals</b>,<b>DocuSign</b>,and <b>Beyond Meat</b> haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.</p><p><blockquote>股份<b>爵士制药</b>,<b>文档签名</b>,和<b>Beyond Meat</b>已经几个月没这么便宜了。所有这些业务都有可能在未来几个月和几年内产生一些强劲的增长数据，这可能意味着您将获得丰厚的回报。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aaa8c5069132f2d41beafbfbef0705f\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社</span></p></blockquote></p><p> <b>1. Jazz Pharmaceuticals</b></p><p><blockquote><b>1. 爵士制药</b></blockquote></p><p> Healthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the <b>S&P 500</b> is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.</p><p><blockquote>医疗保健公司 Jazz Pharmaceuticals 的股价徘徊在 52 周低点附近，今年迄今已下跌 25%，尽管<b>标普500</b>上涨22%。今年 2 月，该公司宣布收购 GW Pharmaceuticals，该公司生产 Epidiolex，一种治疗癫痫发作的大麻药物。大麻市场的疲软（由于令人失望的合法化步伐）可能在一定程度上影响了股价。</blockquote></p><p> Yet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.</p><p><blockquote>然而，该公司仍有希望。爵士乐在11月份公布了最新的季度业绩，收入同比增长39%，达到8.38亿美元。其中一半以上来自新产品或刚刚收购的产品，例如 Epidiolex。尽管投资者担忧，其销售额仍强劲增长 21%。</blockquote></p><p> In fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.</p><p><blockquote>事实上，Epidiolex 使 Jazz 成为这里一个有前途的买家，因为该公司正在寻找新的适应症；此外，它正在向欧洲的新国家推出Epidiolex。从长远来看，这两项举措都可能提振该药物的销售。</blockquote></p><p> Prospects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.</p><p><blockquote>长期盈利前景看起来也很强劲。该公司在过去四个季度中的每个季度都取得了令人印象深刻的 82% 或更高的毛利率。尽管在收购 GW Pharma 后，其利润已陷入亏损，但这并不是投资者应该期望该公司停留的地方。爵士队现在可能是一笔划算的交易。</blockquote></p><p> <b>2. DocuSign</b></p><p><blockquote><b>2. 文档签名</b></blockquote></p><p> Anytime a stock falls more than 40% in a <i>single day</i>, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.</p><p><blockquote>任何时候股票下跌超过 40%<i>单日</i>，值得追问的是市场是否反应过度。DocuSign似乎就是这样。该公司上周公布第三季度业绩时超出了预期。截至 10 月 31 日的销售额同比飙升 42%，达到 5.455 亿美元。该公司还经常吹嘘毛利润接近80%。</blockquote></p><p> Yet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.</p><p><blockquote>然而，这对投资者来说还不够。这家科技公司提供的第四季度收入指引为 5.57 亿至 5.63 亿美元，随后出现抛售，远低于分析师预期的 5.74 亿美元。虽然这一估计低于分析师的数字，但这似乎很难成为价格出现如此令人难以置信的下跌的理由。</blockquote></p><p> Unfortunately, in the era of meme stocks, where companies with questionable growth prospects such as <b>AMC Entertainment</b> can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.</p><p><blockquote>不幸的是，在模因股票时代，增长前景可疑的公司，例如<b>AMC院线</b>可能会飙升超过 1,000%（主要是由于散户投资者的炒作），像 DocuSign 这样的高质量企业也可能在没有充分理由的情况下大幅下跌。由于一个季度的指导而出现如此大幅的抛售，是短期思维的缩影。</blockquote></p><p> DocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.</p><p><blockquote>随着人们重返办公室，不再如此依赖数字签名，DocuSign的需求可能会有所下降。然而，这并不意味着它的增长已经结束。Fortune Business Insights 的分析师预计，到 2027 年，全球数字签名市场的复合年增长率将达到 28.9%。</blockquote></p><p> So despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.</p><p><blockquote>因此，尽管看跌，DocuSign 的天空并没有塌下来，看起来现在可能是一个便宜货。尽管该股已从上周触及的低点反弹，但仍处于 2020 年 6 月以来的最高水平。</blockquote></p><p> <b>3. Beyond Meat</b></p><p><blockquote><b>3. Beyond Meat</b></blockquote></p><p> Another stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.</p><p><blockquote>另一只在发布财报后陷入困境的股票是Beyond Meat。该股股价略高于 70 美元，接近 52 周低点，今年已下跌 43%。考虑到该公司不幸出现了未达盈利预期的趋势，这并不奇怪。然而，随着经济恢复正常，新冠肺炎不再影响对其产品的需求或扰乱供应链，Beyond Meat是一只值得持有的复苏股票。</blockquote></p><p> In 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).</p><p><blockquote>2019年，该公司2.98亿美元的销售额是2018年8800万美元的三倍多。2020 年，销售额进一步上升至 4.07 亿美元，但增长率要低得多，为 37%。截至 10 月 2 日的最新季度，净收入仅增长 13%，达到 1.06 亿美元，而在美国市场，销售额实际上下降了 14%。正是该公司的国际业务使整体数字保持绿色（增长了令人印象深刻的 143%）。</blockquote></p><p></p><p> However, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant <b>McDonald's</b> with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker <b>PepsiCo</b> to develop new products. Beyond Meat also recently launched meatless chicken tenders.</p><p><blockquote>然而，随着恢复正常，公司业绩应该会有所改善。此外，Beyond Meat还有新产品和交易，可以将其推向比以前更高的高度。它正在向快餐巨头供货<b>麦当劳</b>McPlant 汉堡的馅饼，如果事实证明它是成功的，这可能会给业务带来好处。此外，它还与一家软饮料制造商成立了一家合资企业<b>百事可乐</b>开发新产品。Beyond Meat最近也推出了无肉鸡肉。</blockquote></p><p> Things may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.</p><p><blockquote>Beyond Meat的短期内情况可能会很严峻，但有许多催化剂可能会使其股价在一两年内看起来非常便宜。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/09/3-high-growth-stocks-that-are-screaming-buys-in-de/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DOCU":"Docusign","BYND":"Beyond Meat, Inc.","JAZZ":"爵士制药"},"source_url":"https://www.fool.com/investing/2021/12/09/3-high-growth-stocks-that-are-screaming-buys-in-de/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147480652","content_text":"If you're looking to do some Christmas shopping on stocks, there are some incredibly good deals out there right now. The market isn't crashing, but some stocks have been struggling of late that you likely won't regret adding to your portfolio today if you're a long-term investor.\nShares of Jazz Pharmaceuticals,DocuSign,and Beyond Meat haven't been this cheap in months. And all these businesses have the potential to generate some strong growth numbers in the months and years ahead, which could mean great returns for you.\nImage source: Getty Images\n1. Jazz Pharmaceuticals\nHealthcare company Jazz Pharmaceuticals is trading around its 52-week low, down 25% year to date even as the S&P 500 is up 22%. In February, the company announced it was acquiring GW Pharmaceuticals, which makes Epidiolex, a cannabis-based drug that treats seizures. Softness in the cannabis market (due to a disappointing pace in legalization) may in part be affecting the shares.\nYet, the company still has promise. Jazz reported its latest quarterly results in November, and revenue rose 39% year over year to $838 million. Over half of that came from products that were either new or just acquired, such as Epidiolex. Its sales rose a robust 21% despite investor concerns.\nIn fact, Epidiolex is what makes Jazz a promising buy here as the company is looking at new indications for it; plus, it is rolling out Epidiolex to new countries in Europe. Both moves could bolster the drug's sales over the long term.\nProspects for long-term profitability also look strong. The company has generated impressive gross margins of 82% or better in each of the past four quarters. Although its bottom line has fallen into the red after the acquisition of GW Pharma, that's not where investors should expect the company to stay. Jazz could be a steal of a deal right now.\n2. DocuSign\nAnytime a stock falls more than 40% in a single day, it's worth asking whether the market overreacted. That's what looks to have happened with DocuSign. The company beat expectations when it reported third-quarter results last week. Sales for the period ended Oct. 31 soared 42% year over year to $545.5 million. The company also regularly boasts a gross profit of close to 80%.\nYet, that wasn't enough for investors. A sell-off ensued as the tech company provided fourth-quarter revenue guidance of $557 million to $563 million -- and that fell well shy of the $574 million that analysts were expecting. While the estimate is below analysts' figures, that hardly seems to be a reason to warrant such an incredible drop in price.\nUnfortunately, in the era of meme stocks, where companies with questionable growth prospects such as AMC Entertainment can skyrocket over 1,000% -- mainly on hype from retail investors -- high-quality businesses like DocuSign can also fall drastically without a good reason. Such a steep sell-off due to one quarter's guidance is the epitome of short-term thinking.\nDocuSign will likely see demand subside a bit as people return to the office and are no longer relying as much on digital signatures. However, that doesn't mean its growth is over. Analysts from Fortune Business Insights project that the global digital signature market will grow at a compound annual rate of 28.9% through 2027.\nSo despite the bearishness, the sky isn't falling for DocuSign, and it looks like it could be a bargain buy right now. Although the stock has bounced up from the lows it hit last week, it's still around levels not seen since June 2020.\n3. Beyond Meat\nAnother stock that has struggled after releasing earnings is Beyond Meat. At just over $70, the stock is trading near its 52-week lows, having fallen 43% this year.It's not a huge surprise given that the company has an unfortunate trend of missing earnings expectations. Yet, Beyond Meat is a great recovery stock to own as economies see a return to normal and COVID-19 no longer impacts demand for its products or disrupts the supply chain.\nIn 2019, the company's sales of $298 million were more than triple the $88 million it reported in 2018. And in 2020, sales rose further to $407 million but at a much lower growth rate of 37%. For the latest quarter ended Oct. 2, net revenue increased just 13% to $106 million -- and in the U.S. market, sales were actually down 14%. It was the company's international operations that kept the overall numbers in the green (rising by an impressive 143%).\nHowever, the company's performance should improve with a return to normalcy. In addition, Beyond Meat has new products and deals that could propel it to even greater heights than before. It is supplying fast-food giant McDonald's with the patty for its McPlant burger, which could be a boon for the business if it proves to be successful. Plus, it has a joint venture with soft-drink maker PepsiCo to develop new products. Beyond Meat also recently launched meatless chicken tenders.\nThings may look grim in the short term for Beyond Meat, but there are many catalysts out there that could make its stock price today look incredibly cheap in a year or two.","news_type":1,"symbols_score_info":{"DOCU":0.9,"JAZZ":0.9,"BYND":0.9}},"isVote":1,"tweetType":1,"viewCount":3153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875892565,"gmtCreate":1637630280003,"gmtModify":1637630280003,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875892565","repostId":"1171692239","repostType":2,"repost":{"id":"1171692239","kind":"news","pubTimestamp":1637582731,"share":"https://www.laohunote.com/m/news/1171692239?lang=zh_CN&edition=full","pubTime":"2021-11-22 20:05","market":"us","language":"en","title":"Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作，将其算法用于mRNA疫苗和疗法开发</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171692239","media":"Reuters","summary":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its ","content":"<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p><p><blockquote>路透北京 11 月 22 日 - 中国科技巨头百度 (9888.HK) 周一表示，已将其信使 RNA (mRNA) 序列算法授权给赛诺菲公司，用于设计疫苗和治疗产品，这是其与全球主要制药商达成的首个此类商业协议。</blockquote></p><p> Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p><p><blockquote>赛诺菲 (SASY.PA) 在大流行之前是世界上最大的疫苗制造商之一，但这家法国公司在开发针对 COVID-19 的 mRNA 疫苗方面被竞争对手 BioNTech /辉瑞 (PFE.N) 和 Moderna (MRNA.O) 击败。阅读更多</blockquote></p><p> Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p><p><blockquote>赛诺菲于 9 月份停止了自己的 mRNA COVID-19 疫苗试验，转而专注于与葛兰素史克 (GSK.L) 合作，将另一种基于更传统的蛋白质方法的 COVID-19 候选疫苗推向市场。</blockquote></p><p> The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p><p><blockquote>法国集团Saidit将把其mRNA资源集中在其他有强烈未满足需求的传染病和治疗药物上。</blockquote></p><p> Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p><p><blockquote>领导该项目的百度科学家黄亮表示，当赛诺菲使用其算法发现的任何基于mRNA的疗法或候选疫苗进入临床试验时，百度将获得里程碑式的付款。</blockquote></p><p> \"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p><p><blockquote>黄告诉路透社：“该协议包括里程碑付款的事实表明，[赛诺菲]对将采用百度算法开发的候选药物纳入临床试验并推向市场充满信心。”他拒绝透露交易规模。</blockquote></p><p> An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p><p><blockquote>基于mRNA的疫苗含有mRNA序列，该序列指示人体细胞产生可以刺激免疫系统采取行动的蛋白质。</blockquote></p><p> Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p><p><blockquote>黄说，百度的算法旨在提供更多优化的mRNA序列，有早期迹象表明，它可能比标准算法更适合疫苗和治疗药物开发。</blockquote></p><p> Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.</p><p><blockquote>具体到新冠肺炎候选疫苗，根据实验室研究和动物测试，那些含有百度算法生成的mRNA序列的疫苗更稳定，并且似乎需要比基于标准算法的基线注射更小的剂量，这些疫苗尚未经过同行评审。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作，将其算法用于mRNA疫苗和疗法开发</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development<blockquote>百度与赛诺菲合作，将其算法用于mRNA疫苗和疗法开发</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-22 20:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p><p><blockquote>路透北京 11 月 22 日 - 中国科技巨头百度 (9888.HK) 周一表示，已将其信使 RNA (mRNA) 序列算法授权给赛诺菲公司，用于设计疫苗和治疗产品，这是其与全球主要制药商达成的首个此类商业协议。</blockquote></p><p> Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p><p><blockquote>赛诺菲 (SASY.PA) 在大流行之前是世界上最大的疫苗制造商之一，但这家法国公司在开发针对 COVID-19 的 mRNA 疫苗方面被竞争对手 BioNTech /辉瑞 (PFE.N) 和 Moderna (MRNA.O) 击败。阅读更多</blockquote></p><p> Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p><p><blockquote>赛诺菲于 9 月份停止了自己的 mRNA COVID-19 疫苗试验，转而专注于与葛兰素史克 (GSK.L) 合作，将另一种基于更传统的蛋白质方法的 COVID-19 候选疫苗推向市场。</blockquote></p><p> The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p><p><blockquote>法国集团Saidit将把其mRNA资源集中在其他有强烈未满足需求的传染病和治疗药物上。</blockquote></p><p> Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p><p><blockquote>领导该项目的百度科学家黄亮表示，当赛诺菲使用其算法发现的任何基于mRNA的疗法或候选疫苗进入临床试验时，百度将获得里程碑式的付款。</blockquote></p><p> \"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p><p><blockquote>黄告诉路透社：“该协议包括里程碑付款的事实表明，[赛诺菲]对将采用百度算法开发的候选药物纳入临床试验并推向市场充满信心。”他拒绝透露交易规模。</blockquote></p><p> An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p><p><blockquote>基于mRNA的疫苗含有mRNA序列，该序列指示人体细胞产生可以刺激免疫系统采取行动的蛋白质。</blockquote></p><p> Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p><p><blockquote>黄说，百度的算法旨在提供更多优化的mRNA序列，有早期迹象表明，它可能比标准算法更适合疫苗和治疗药物开发。</blockquote></p><p> Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.</p><p><blockquote>具体到新冠肺炎候选疫苗，根据实验室研究和动物测试，那些含有百度算法生成的mRNA序列的疫苗更稳定，并且似乎需要比基于标准算法的基线注射更小的剂量，这些疫苗尚未经过同行评审。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","SNYNF":"Sanofi","09888":"百度集团-SW"},"source_url":"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171692239","content_text":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.\nSanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more\nSanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.\nThe French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.\nBaidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.\n\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.\nAn mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.\nBaidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.\nSpecifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.","news_type":1,"symbols_score_info":{"09888":0.9,"BIDU":0.9,"SNYNF":0.9}},"isVote":1,"tweetType":1,"viewCount":4194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876512628,"gmtCreate":1637331273530,"gmtModify":1637331273657,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876512628","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohunote.com/m/news/1144455380?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和 BioNTech SE 的股价在盘前交易中上涨约 2%，此前它们获得了美国 FDA 扩大的加强剂紧急使用授权，将 18 岁及以上的个人包括在内。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），将18岁及以上的个人包括在内。加强剂量应在初级系列完成后至少六个月施用，剂量强度与初级系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>“辉瑞公司董事长兼首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们抗击 COVID-19 的两年大关接近，我们又达到了一个重要的里程碑，扩大了 18 岁及以上人群接种 COVID-19 疫苗加强剂量的授权。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>“BioNTech公司首席执行官兼联合创始人、医学博士乌古尔-沙欣（Ugur Sahin）说：”今天美国食品和药物管理局的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后会产生强劲的免疫反应，甚至超过了高效的两剂初级接种方案完成后的免疫反应。“这些数据表明，我们疫苗的加强剂量有可能对包括德尔塔在内的测试变种保持高水平的保护”。</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10 月，两家公司宣布了该试验的积极顶线结果显示，与未接受加强剂的人相比，对先前接受辉瑞-BioNTech 初级两剂系列的个体施用的加强剂量显示出 95% 的相对疫苗效力。到目前为止，这些是任何随机对照新冠肺炎疫苗加强试验中披露的第一个也是唯一一个疗效数据。不良事件概况与疫苗的其他临床安全性数据大致一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在65岁及以上的个体、18至64岁的严重新冠肺炎高风险个体和18至64岁的个体中紧急使用。经常在机构或职业中接触新型冠状病毒的18至64岁的个体，以及已完成不同授权新冠肺炎疫苗初次接种的合格个体。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和 BioNTech 根据与美国政府的现有供应协议继续供应疫苗，包括足够数量的加强剂，该协议将持续到 2022 年 4 月。这些公司预计今天的消息不会影响与世界各国政府和国际卫生组织现有的供应协议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和 BioNTech SE 的股价在盘前交易中上涨约 2%，此前它们获得了美国 FDA 扩大的加强剂紧急使用授权，将 18 岁及以上的个人包括在内。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），将18岁及以上的个人包括在内。加强剂量应在初级系列完成后至少六个月施用，剂量强度与初级系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>“辉瑞公司董事长兼首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们抗击 COVID-19 的两年大关接近，我们又达到了一个重要的里程碑，扩大了 18 岁及以上人群接种 COVID-19 疫苗加强剂量的授权。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>“BioNTech公司首席执行官兼联合创始人、医学博士乌古尔-沙欣（Ugur Sahin）说：”今天美国食品和药物管理局的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后会产生强劲的免疫反应，甚至超过了高效的两剂初级接种方案完成后的免疫反应。“这些数据表明，我们疫苗的加强剂量有可能对包括德尔塔在内的测试变种保持高水平的保护”。</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10 月，两家公司宣布了该试验的积极顶线结果显示，与未接受加强剂的人相比，对先前接受辉瑞-BioNTech 初级两剂系列的个体施用的加强剂量显示出 95% 的相对疫苗效力。到目前为止，这些是任何随机对照新冠肺炎疫苗加强试验中披露的第一个也是唯一一个疗效数据。不良事件概况与疫苗的其他临床安全性数据大致一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在65岁及以上的个体、18至64岁的严重新冠肺炎高风险个体和18至64岁的个体中紧急使用。经常在机构或职业中接触新型冠状病毒的18至64岁的个体，以及已完成不同授权新冠肺炎疫苗初次接种的合格个体。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和 BioNTech 根据与美国政府的现有供应协议继续供应疫苗，包括足够数量的加强剂，该协议将持续到 2022 年 4 月。这些公司预计今天的消息不会影响与世界各国政府和国际卫生组织现有的供应协议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871904658,"gmtCreate":1637016989498,"gmtModify":1637016989498,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"[OMG] ","listText":"[OMG] ","text":"[OMG]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871904658","repostId":"1172705595","repostType":4,"isVote":1,"tweetType":1,"viewCount":5786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857874840,"gmtCreate":1635519984474,"gmtModify":1635519984474,"author":{"id":"3573647345754035","authorId":"3573647345754035","name":"Shlee","avatar":"https://static.tigerbbs.com/4252964386d65759fde597203ee9a21f","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573647345754035","idStr":"3573647345754035"},"themes":[],"title":"","htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/857874840","repostId":"2179105882","repostType":4,"isVote":1,"tweetType":1,"viewCount":5029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}